Association of deep‐learning–derived brain computed tomography measures with cognition and blood‐based biomarkers of neurodegenerative diseases
Meera Srikrishna(University of Gothenburg), Michael Schöll(Wallenberg Wood Science Center), Rolf A. Heckemann(Imperial College London), Joel Simrén(University of Gothenburg), Bibek Gyanwali(Erasmus MC), Christopher Chen(National University of Singapore), Kaj Blennow(Sahlgrenska University Hospital), Lars‐Olof Wahlund(Karolinska Institutet), Anna Zettergren(University of Gothenburg), Ingmar Skoog(Sahlgrenska University Hospital), Joyce R. Chong(National University of Singapore), Saima Hilal(National University of Singapore), Danielle van Westen(Lund University), Silke Kern(University of Gothenburg), Henrik Zetterberg(University of Wisconsin–Madison), Eric Westman(Wellcome Centre for Human Neuroimaging), Nicholas J. Ashton(King's College London), Joana B. Pereira(Malmö University), Giovanni Volpe(Volvo (Sweden))
Cited by 0
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Active Particles in Complex and Crowded Environments
|Reviews of Modern Physics|2016|2.9k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k